Business description
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses.
Management board & Supervisory board
| CEO |
| Charles Kummeth |
| Management board |
| Jim Hippel, Kim Kelderman, Will Geist, Shane Bohnen, Peter Breloer, Qi Cheng, Steve Crouse, Brenda S. Everson, Bob Gavin, Lynne Hohlfeld, Evett Kruka, Steven Silverman, Kevin Smyth, Peter Schuessler |
| Supervisory board |
| Robert V. Baumgartner, Charles Kummeth, Dr. Alpna Seth, Dr. Joseph D. Keegan, Dr. Randolph C. Steer, Dr. Roland Nusse, Dr. Rupert Vessey, John L. Higgins, Julie L. Bushman |
Company data
| Name: |
Bio-Techne Corp. |
| Address: |
614 McKinley Place N.E.,Minneapolis, MN 55413, USA |
| Phone: |
+1-612-379-2956 |
| Fax: |
+1-612-656-4400 |
| E-mail: |
info@bio-techne.com
|
| Internet: |
bio-techne.com/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
06-30 |
| Free Float: |
79.40% |
| IPO date: |
1989-05-08 |
Investor relations
| Name: |
David Clair |
| IR phone: |
+1-612-656-4416 |
| IR Fax: |
- |
| IR e-mail: |
ir@bio-techne.com
|
